GALMED PHARMACEUTICALS LTD. Accumulated Other Comprehensive Income
GALMED PHARMACEUTICALS LTD. (GLMD) had Accumulated Other Comprehensive Income of -$331.00 thousand as of 2026-06-30, per its 6-K filed 2026-09-02.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2026-09-02
- 2026-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$331.00K.
- 2025-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$303.00K.
- 2025-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$316.00K.
- 2025-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$403.00K.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax |
|---|---|
| 2026-06-30 | -$331.00K 6-K · filed 2026-09-02 |
| 2025-12-31 | -$303.00K 6-K · filed 2026-09-02 |
| 2025-09-30 | -$316.00K 6-K · filed 2025-11-26 |
| 2025-06-30 | -$403.00K 6-K · filed 2025-08-28 |
| 2024-12-31 | -$416.00K 20-F · filed 2026-03-31 |
| 2024-06-30 | -$435.00K 6-K · filed 2024-08-28 |
| 2023-12-31 | -$454.00K 20-F · filed 2025-04-02 |
| 2023-06-30 | -$662.00K 6-K · filed 2023-08-09 |
| 2022-12-31 | -$745.00K 20-F · filed 2024-04-04 |
| 2022-06-30 | -$982.00K 6-K · filed 2022-08-04 |
| 2021-12-31 | -$171.00K 20-F · filed 2023-03-29 |
| 2021-06-30 | $108.00K 6-K · filed 2021-08-05 |
| 2020-12-31 | $272.00K 20-F · filed 2022-05-02 |
| 2020-06-30 | $498.00K 6-K · filed 2020-08-06 |
| 2019-12-31 | $35.00K 20-F · filed 2021-03-18 |
| 2019-06-30 | $41.00K 6-K · filed 2019-08-05 |
| 2018-12-31 | -$11.00K 20-F · filed 2020-03-12 |
| 2018-06-30 | -$29.00K 6-K · filed 2018-08-02 |
| 2017-12-31 | -$7.00K 20-F · filed 2019-03-13 |
| 2017-06-30 | -$20.00K 6-K · filed 2017-07-31 |
| 2016-12-31 | -$85.00K 20-F · filed 2018-03-13 |
| 2016-06-30 | -$104.00K 6-K · filed 2017-06-23 |
| 2015-12-31 | -$206.00K 6-K · filed 2017-06-23 |
| 2014-12-31 | $4.00K 20-F · filed 2016-03-22 |
| 2013-12-31 | $0.00 20-F · filed 2015-03-31 |